← Leaderboards
Hai Yan
Duke University
$6,159,680
Attributed
$6,852,936
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.1M · FY2006–19$2M$1.5M$1M$500K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$6,852,936 · 4
By mechanism
R01$6,852,936 · 4
Top collaborators
- John H Sampson4 shared
Most similar at Duke University
Same institution · by research overlap
- John H Sampson$43,413,436
- David Reardon$8,732,934
- Benjamin Aaron Alman$12,504,961
- Michael Barry Kastan$65,974,699
- Joel H Collier$16,512,069
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsMutationBaseTherapeutic InterventionPathway InteractionsMalignant NeoplasmsGliomaClassificationMutantGlioblastomaMolecularGeneticTumorGrowthOncogenicSmall MoleculeInhibitor/AntagonistCell GrowthTherapeutic TargetBrain NeoplasmsLaboratoriesMalignant Neoplasm Of BrainMetabolicMetabolism
Grant awards (25)
The Role of IDH1 Mutations in Gliomagenesis and Metabolism$366,296
R01 · FY2019 · CA · contact PI
The Role of IDH1 Mutations in Gliomagenesis and Metabolism$377,625
R01 · FY2018 · CA · contact PI
Role of GLUD2 as a metabolic driver of gliomas with IDH1 mutations$347,813
R01 · FY2018 · NS · contact PI
The Role of IDH1 Mutations in Gliomagenesis and Metabolism$377,625
R01 · FY2017 · CA · contact PI
Role of GLUD2 as a metabolic driver of gliomas with IDH1 mutations$347,813
R01 · FY2017 · NS · contact PI
Brain Tumor Targeting Using Tumor-Specific Neuroimmunology$347,813
R01 · FY2017 · NS
The Role of IDH1 Mutations in Gliomagenesis and Metabolism$377,625
R01 · FY2016 · CA · contact PI
Role of GLUD2 as a metabolic driver of gliomas with IDH1 mutations$347,813
R01 · FY2016 · NS · contact PI
Brain Tumor Targeting Using Tumor-Specific Neuroimmunology$347,813
R01 · FY2016 · NS
The Role of IDH1 Mutations in Gliomagenesis and Metabolism$376,438
R01 · FY2015 · CA · contact PI
Brain Tumor Targeting Using Tumor-Specific Neuroimmunology$347,448
R01 · FY2015 · NS
Brain Tumor Targeting Using Tumor-Specific Neuroimmunology$343,438
R01 · FY2014 · NS
Role of IDH1 and IDH2 Mutations in Glioma Cellular Biology and Pathogenesis$288,091
R01 · FY2013 · CA · contact PI
Role of IDH1 and IDH2 Mutations in Glioma Cellular Biology and Pathogenesis$306,846
R01 · FY2012 · CA · contact PI
Role of IDH1 and IDH2 Mutations in Glioma Cellular Biology and Pathogenesis$61,116
R01 · FY2012 · CA · contact PI
Role of IDH1 and IDH2 Mutations in Glioma Cellular Biology and Pathogenesis$307,198
R01 · FY2011 · CA · contact PI
Role of IDH1 and IDH2 Mutations in Glioma Cellular Biology and Pathogenesis$61,486
R01 · FY2011 · CA · contact PI
Role of IDH1 and IDH2 Mutations in Glioma Cellular Biology and Pathogenesis$316,888
R01 · FY2010 · CA · contact PI
The Role of OTX2 in Molecular Pathogenesis of Medulloblastoma$215,096
R01 · FY2010 · CA · contact PI
The Role of OTX2 in Molecular Pathogenesis of Medulloblastoma$64,534
R01 · FY2010 · CA · contact PI
The Role of OTX2 in Molecular Pathogenesis of Medulloblastoma$215,096
R01 · FY2009 · CA · contact PI
The Role of OTX2 in Molecular Pathogenesis of Medulloblastoma$60,080
R01 · FY2009 · CA · contact PI
The Role of OTX2 in Molecular Pathogenesis of Medulloblastoma$215,096
R01 · FY2008 · CA · contact PI
The Role of OTX2 in Molecular Pathogenesis of Medulloblastoma$215,039
R01 · FY2007 · CA · contact PI
The Role of OTX2 in Molecular Pathogenesis of Medulloblastoma$220,810
R01 · FY2006 · CA · contact PI